India and drug #patents : The Ghost of #Glivec haunts #Sovaldi

Apothecurry welcomes back guest columnist Dr Kristina Lybecker. Her latest column is an elegantly simple "where the rubber hits the road" exposition of the recent rejection of patents on US biopharma company Gilead's Hepatitis C drug Sovaldi in India. Coincidentally, Gilead's European patent on Sovaldi was challenged yesterday by charity Medicins du Monde marking yet … Continue reading India and drug #patents : The Ghost of #Glivec haunts #Sovaldi

Advertisement